Regional AMI Care: Bridging the Rural Health Care Gap Darren B. Bean, MD University of Wisconsin Emergency Medicine/Medflight Director UW Level 1 Heart.

Slides:



Advertisements
Similar presentations
GUSTO-IV AMI G lobal U se of S trategies T o Open O ccluded Coronary Arteries in AMI.
Advertisements

BASE HOSPITAL GROUP ONTARIO Chapter 3 for 12 Lead Training -WHY 12 LEAD- Ontario Base Hospital Group Education Subcommittee 2008 TIME IS MUSCLE.
Chapter 3 for 12 Lead Training -Precourse-
Presented by: Fahim H. Jafary, M.D., F.A.C.C. Associate Professor of Medicine Aga Khan University Hospital, Karachi March 14, 2008 Primary Percutaneous.
A Pharmaco-invasive Reperfusion Strategy with Immediate Percutaneous Coronary Intervention is Safe and Effective in ST-Elevation Myocardial Infarction.
EMS and D2B in Pennsylvania Douglas F. Kupas, MD, FACEP Commonwealth EMS Medical Director Bureau of EMS PA Department of Health.
“ If physicians would read two articles per day out of the six million medical articles published annually, in one year, they would fall 82 centuries behind.
Regional Systems of Care to Optimize Timeliness of Reperfusion Therapy for STEMI: The Mayo Clinic Protocol Henry H. Ting, MD, MBA Associate Professor of.
Relationship of Time to Treatment and Door-to-Balloon Time to Mortality in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty Christopher.
Management of Acute Myocardial Infarction Minimal Acceptable vs Optimal Care Hussien H. Rizk, MD Cairo University.
Current and Future Perspectives on Acute Coronary Syndromes Paul W. Armstrong MD AMI Quebec Montreal October 1, 2010.
An Immediate Nursing Feedback Program for Primary PCI for ST-segment Elevation Myocardial Infarction Karen Mckenny RN, Theresa Fortner RN, Cheryl McNeil.
STEMI: What’s the Rush? STEMI: What’s the Rush? William Phillips, MD, FACC, FSCAI Director of Cardiology CMMC A PCI Center perspective.
Improved Care for Acute Myocardial Infarction Linking Referral and Receiving Centres – How can We Communicate Better? Dr. James McMeekin AMI Faculty Cardiologist,
Primary PCI Treatment of choice for Acute MI.
Time Is Myocardium and the Wavefront of Necrosis CM Gibson 2002.
GUSTO I GUSTO I Median Time (hrs) Between Symptom Onset and Treatment GUSTO III GUSTO III InTIME II InTIME II ASSENT.
Perspective on COMMIT/CCS-2 Trial of Clopidogrel in STEMI Christopher Cannon, M.D. Brigham and Women’s Hospital Boston, MA.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
GP IIb/IIIa Inhibition in STEMI: Growing Clinical Trial Evidence.
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
ACS and Thrombosis in the Emergency Setting
AMI Strategy How to Achieve Door-to-Balloon Times of 90 Minutes and What to Do Next? Aaron Kugelmass, MD Director, Cardiac Cath Lab Associate Division.
A modern thrombolysis service is superior to primary angioplasty
Regional Showcase West Tennessee. Speakers: John Baker M.D./Emily Garner RN Presentation: Regional Showcase – West Tennessee Presenter Disclosure Information.
Role of Percutaneous coronary intervention (PCI) after thrombolytic therapy By Dr. Mohamed Mahros Assistant lecturer of cardiology Benha faculty of medicine.
Management Of AMI Does time matter?? What is the best strategy: PPCI Vs TT.
Initiating Antiplatelet Therapy in Patients with Atherothrombosis
National AMI Information Call February 5, 2008 Patient Safety Initiative.
Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction The HORIZONS-SWITCH Analysis HORIZONS AMI Dangas G, et al.
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
Myocardial Ischaemia National Audit Project Are we replacing good fibrinolytic treatment with poor primary PCI? John Birkhead who has NO CONFLICT OF INTEREST.
Rescue Angioplasty versus Conservative Therapy or Repeat Thrombolysis Trial Presented at American Heart Association Scientific Sessions 2004 Presented.
Eddy Lang MD Attending Staff Emergency Department Jewish General Hospital Update in reperfusion therapy for acute myocardial infarction.
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
The 90 Minute Wall: 60% Rates of TIMI Grade 3 Flow % TIMI 3 Flow.
The Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented.
Acute Coronary Syndromes SIGN 93. MINAP Mortality after Acute Coronary Syndromes Cumulative: 13.6% Blue 10.6% Green 11.6% Red.
False Positive ST Elevation in Patients Undergoing Direct Percutaneous Coronary Intervention David M. Larson MD, Katie M. Menssen, BS,, Scott W Sharkey.
Atypical Presentations Patients older than 75: frequently no chest pain ECG in evolution (nonspecific ECG changes) Diabetic patients: commonly no chest.
PCI for STEMI Ari de la Hera, M.D..
1 Advanced Angioplasty London, England 27 January, 2006 Jörg Michael Rustige,MD Medical Director Lilly Critical Care Europe, Geneva.
Inter-Hospital Transfer of High Risk STEMI Patients for PCI is Safe and Feasible David M. Larson, Katie M. Menssen, Scott W. Sharkey, Marc C. Newell, Anil.
Risk of bolus thrombolytics Shamir Mehta, MD Director, Coronary Care Unit McMaster University Medical Center Hamilton, Ontario Paul Armstrong, MD Professor.
NSTE Acute Coronary Syndromes
RACE: Reperfusion of acute myocardial infarction in North Carolina emergency departments Christopher Granger, MD Director, Cardiac Care Unit Duke University.
VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
Annual Patient Admissions for Acute Coronary Syndromes 1.4 MM Non-ST elevation ACS 0.6 MM ST-elevation MI ~ 2.0 MM patients admitted to CCU or telemetry.
S. Chiu Wong MD, FACC Associate Professor of Medicine Weill Medical College of Cornell University Director, Cardiac Catheterization Laboratories The New.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2007 Focused Update of the ACC/AHA 2004 Guidelines.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
Heart Alert Quandary Kiran K. Cheruku, MD Interventional Cardiologist Heart And Vascular Institute of Texas.
No conflicts of interest or financial ties to disclose.
SPEED : GUSTO-IV PILOT GUSTO-IV Pilot Trial. SPEED : GUSTO-IV PILOT Rationale for Combination Therapy in AMI Enhance Incidence and Speed of Reperfusion.
Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented at.
Rationale for the Clinical Evaluation of Combination GP IIb-IIIa Inhibitor and Low-Dose Fibrinolytic Therapy in ST-Elevation Myocardial Infarction.
Ischemic Heart Disease/MI Review
Dartmouth Hitchcock Medical Center
Management of ST-Elevation Myocardial Infarction
Eva Kline-Rogers RN, NP, AACC University of Michigan
ASSENT-3 PLUS 1,639 patients with STEMI Treatment Group A
Ischaemic Heart Disease Acute Coronary Syndrome
The DANAMI-2 Trial Danish Trial in Acute Myocardial Infarction-2
Brief History on Mission: Lifeline
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
American College of Cardiology Presented by Dr. Michel R. Le May
Circulation 2001;104: Circulation 2001;104:
European Heart Journal Advance Access
CRITICAL/CLINICAL PATHWAYS ACUTE CORONARY SYNDROMES
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Regional AMI Care: Bridging the Rural Health Care Gap Darren B. Bean, MD University of Wisconsin Emergency Medicine/Medflight Director UW Level 1 Heart Attack Program

Historical Perspective 1960’s Bedrest for 3 to 4 weeks Morphine sulfate 1970’s Coronary care units Intra-aortic balloon pump CABG surgery In-hospital mortality: 15% In-hospital mortality: 30%

1980’s Concept of Coronary thrombosis

Frequency of Arterial Occlusion in Acute MI * ** N N Hours of Chest Pain Percent Total Occlusion *p<0.05 **p<0.01 DeWood, et al. N Engl J Med 1980;303:897

1980’s The Revolution Begins: Thrombolytics Race for the ‘holy grail’

1988: ISIS-2 Cumulative Vascular Mortality Days Lancet 1988;2:342 SK and Aspirin SK Aspirin Placebo N=17, % 10.7% 10.4% 8.0%

Complication of Thrombolytics

ICH in Major AMI Trials GUSTO III % of Patients ASSENT II GUSTO V t-PAr-PAt-PATNKr-PA Abx +  r-PA SKt-PA p = NS n-PAt-PA InTIME II p = 0.004p = 0.03 GUSTO I Fibrinolytic Trial Experience

Thrombolytic Therapy: Benefit 30 % relative risk reduction in short term mortality (7-10%) 30 % relative risk reduction in short term mortality (7-10%) Benefit persists >10 years Benefit persists >10 years Despite benefit, up to 1/3 of STEMI patients receive no reperfusion therapy Despite benefit, up to 1/3 of STEMI patients receive no reperfusion therapy Fear of bleeding complication Fear of bleeding complication

Thrombolytic Therapy: Limitations 20% fail to restore vessel patency 20% fail to restore vessel patency 40-50% fail to restore TIMI 3 flow 40-50% fail to restore TIMI 3 flow 10-15% re-occlusion rate 10-15% re-occlusion rate 0.5-1% rate of intracranial hemorrhage 0.5-1% rate of intracranial hemorrhage

Angioplasty (PCI) Andreas Gruentzig 1977 Andreas Gruentzig 1977 >1,000,000 PCI procedures in US annually >1,000,000 PCI procedures in US annually >2,000,000 performed worldwide annually >2,000,000 performed worldwide annually

PTCA in Acute MI Definitions Primary (Immediate) - Initial strategy Primary (Transfer) Salvage (Rescue) - Thrombolytic failure Elective - Recurrent ischemia post-MI

Is primary angioplasty superior to thrombolysis? YES - if the right conditions exist: 1) Performed quickly 2) Experienced operator 3) High volume cardiac center

Thrombolytics: Clot age predicts reperfusion rate Very effective in fresh clot Very effective in fresh clot Up to 25% may fully abort if administered <1hr symptom onset Up to 25% may fully abort if administered <1hr symptom onset After 120 minutes dramatic fall in reperfusion rates After 120 minutes dramatic fall in reperfusion rates Mortality benefit dependent on TIMI 3 flow!! Mortality benefit dependent on TIMI 3 flow!!

Transfer for PCI: European Experience

High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs Lytic therapy Front-loaded tPA 100 mg (n=782) Lytic therapy Front-loaded tPA 100 mg (n=782) Death / MI / Stroke at 30 Days DANAMI-2: Study Design Primary PCI with transfer (n=567) Primary PCI with transfer (n=567) Primary PCI without transfer (n=223) Primary PCI without transfer (n=223) Stopped early by safety and efficacy committee

Lytic Primary PCI P=0.35 Death DANAMI-2: Results Lytic Primary PCI P=0.15 Stroke Lytic Primary PCI P< Recurrent MI

Mean time to treatment delayed 44minMean time to treatment delayed 44min

Risk associated with helicopter transfer?

Have we been able to reproduce the European experience?

US Performance 2002: NRMI 4 NRMI 4 Transfer-In Annual Data Report 2002 Door to ECG. Door to ECG. ECG to Cath Lab Arrival ECG to Cath Lab Arrival Cath Lab to Balloon. Cath Lab to Balloon Door to Balloon: 198 minutes (25 th : 137; 75 th : 281) Gibson CM, ,292 patients Percent < 90 Min.: 4.8%

Re-examining the door to balloon inflation window How long is too long for primary PCI assuming door to needle (lytic) of 30 min? How long is too long for primary PCI assuming door to needle (lytic) of 30 min? Recent ACC/AHA guidelines reduce door to balloon inflation time to 90 min (including transferred patients) Recent ACC/AHA guidelines reduce door to balloon inflation time to 90 min (including transferred patients)

Nallamothu et al, Am J Cardiol 2003 Absolute Difference Risk of Death (%) Time in Minutes Favors PCI Favors Lytic - 13 RCT’s patients - P=0.04

Transfer for Primary PCI Mortality benefit of primary PCI exists when treatment is delayed no more than 60min Mortality benefit of primary PCI exists when treatment is delayed no more than 60min Relative risk of death increase 1.08 for every delay in 30 min from symptom onset to restoration of TIMI 3 flow Relative risk of death increase 1.08 for every delay in 30 min from symptom onset to restoration of TIMI 3 flow

‘Let’s go get a Starbucks’

Regionalized Cardiac Care “Golden Hour” “Ultra-Aggressive” Trauma Model “Ultra-Aggressive” Trauma Model Alliance between regional EMS, referral centers, air-medical services, and tertiary cardiac centers. Alliance between regional EMS, referral centers, air-medical services, and tertiary cardiac centers.

Regionalized Cardiac System Mayo Clinic 236 patients from 28 community ED’s 236 patients from 28 community ED’s Lytics for symptoms <3 hours: Lytics for symptoms <3 hours: PPCI symptoms >3 hours PPCI symptoms >3 hours Primary Angioplasty: D2B 116 min (12% <90min) Lytics: 36% required rescue PCI No deaths in transfer

Regionalized Cardiac System Minneapolis 1345 patients from 30 Referral centers 1345 patients from 30 Referral centers Mileage determined treatment: Mileage determined treatment: <60miles: PPCI <60miles: PPCI >60miles: Facilitated PCI (1/2 dose lytics) >60miles: Facilitated PCI (1/2 dose lytics) A Regional System to Provide Timely Access to Percutaneous Coronary Intervention; Henry et al; Circulation, Aug 2007: 116 (7)

Regionalized Cardiac System Minneapolis <60 miles <60 miles D2B 95min (25 th 82min, 75 th 116min) D2B 95min (25 th 82min, 75 th 116min) >60 miles >60 miles D2B 120min (25 th 100min, 75 th 145min) D2B 120min (25 th 100min, 75 th 145min) A Regional System to Provide Timely Access to Percutaneous Coronary Intervention; Henry et al; Circulation, Aug 2007: 116 (7)

ED to UW Call Received

Transfer Process

Cath lab Helicopter

Symptom onset 911 EMS Arrival EMS Departure Community ED Arrival ECG Call UW Medflight Activation Cath lab Activation Skids up Medflight Arrival Medflight Departure UW Arrival Cath lab Arrival Balloon Inflation Variable target intervals Variable non-target intervals Fixed intervals

Focus on ‘Variable’ Time Intervals Community ED arrival to call received Community ED arrival to call received Call received to system activation Call received to system activation Helicopter response time Helicopter response time Helicopter ground time Helicopter ground time Arrival to balloon inflation Arrival to balloon inflation

Focus on ‘Variable’ Time Intervals Community ED arrival to call received Community ED arrival to call received Call received to system activation Call received to system activation Helicopter response time Helicopter response time Helicopter ground time Helicopter ground time Arrival to balloon inflation Arrival to balloon inflation Education Education Goal ECG <10 min Goal ECG <10 min UW call < 15 min UW call < 15 min

Focus on ‘Variable’ Time Intervals Community ED arrival to call received Community ED arrival to call received Call received to system activation Call received to system activation Helicopter response time Helicopter response time Helicopter ground time Helicopter ground time Arrival to balloon inflation Arrival to balloon inflation “Accept always” policy “Accept always” policy Community ED Physician Activates System (no filters) Community ED Physician Activates System (no filters)

Focus on ‘Variable’ Time Intervals Community ED arrival to call received Community ED arrival to call received Call received to system activation Call received to system activation Helicopter response time Helicopter response time Helicopter ground time Helicopter ground time Arrival to balloon inflation Arrival to balloon inflation ‘Priority dispatch’ ‘Priority dispatch’ Lift first – patient info en route Lift first – patient info en route

Focus on ‘Variable’ Time Intervals Community ED arrival to call received Community ED arrival to call received Call received to system activation Call received to system activation Helicopter response time Helicopter response time Helicopter ground time Helicopter ground time Arrival to balloon inflation Arrival to balloon inflation Standard medications Standard medications No IV infusions No IV infusions ED – Medflight nurse coordination ED – Medflight nurse coordination

Focus on ‘Variable’ Time Intervals Community ED arrival to call received Community ED arrival to call received Call received to system activation Call received to system activation Helicopter response time Helicopter response time Helicopter ground time Helicopter ground time Arrival to balloon inflation Arrival to balloon inflation Early activation Early activation

Build Your Team

Build Your Tools

PCI vs ‘Lyse n Load’: Mileage

PCI vs ‘Lyse n Load’: Symptom Duration

PCI vs ‘Lyse n Load’: Time Prediction Model

The Transfer Cocktail: What do we really need? ASA ASA Metoprolol Metoprolol Clopridogel Clopridogel Nitroglycerine Nitroglycerine Heparin/LMWH Heparin/LMWH IIb-IIIa inhibitors IIb-IIIa inhibitors Lytics Lytics

The Transfer Cocktail: What do we really need? ASA ASA Metoprolol Metoprolol Clopridogel Clopridogel Nitroglycerine Nitroglycerine Heparin/LMWH Heparin/LMWH IIb-IIIa inhibitors IIb-IIIa inhibitors Lytics Lytics Standard Standard

The Transfer Cocktail: What do we really need? ASA ASA Metoprolol Metoprolol Clopridogel Clopridogel Nitroglycerine Nitroglycerine Heparin/LMWH Heparin/LMWH IIb-IIIa inhibitors IIb-IIIa inhibitors Lytics Lytics AHA class 1 AHA class 1 No morbidity/mortality benefit in STEMI No morbidity/mortality benefit in STEMI No difference in IV/Sublingual No difference in IV/Sublingual 1” paste = 20 mcg/min 1” paste = 20 mcg/min 20-30min steady-state

The Transfer Cocktail: What do we really need? ASA ASA Metoprolol Metoprolol Clopridogel Clopridogel Nitroglycerine Nitroglycerine Heparin/LMWH Heparin/LMWH IIb-IIIa inhibitors IIb-IIIa inhibitors 1-2” nitro paste 1-2” nitro paste Sublingual bridge Sublingual bridge

The Transfer Cocktail: What do we really need? ASA ASA Metoprolol Metoprolol Clopridogel Clopridogel Nitroglycerine Nitroglycerine Heparin/LMWH Heparin/LMWH IIb-IIIa inhibitors IIb-IIIa inhibitors

The Transfer Cocktail: What do we really need? ASA ASA Metoprolol Metoprolol Clopridogel Clopridogel Nitroglycerine Nitroglycerine Heparin/LMWH Heparin/LMWH IIb-IIIa inhibitors IIb-IIIa inhibitors Block platelet plug Block platelet plug Increased TIMI 2-3 flow upon cath lab arrival Increased TIMI 2-3 flow upon cath lab arrival No mortality with early vs cath lab initiation No mortality with early vs cath lab initiation

Bottom Line Standard STEMI ‘Cocktail’ Standard STEMI ‘Cocktail’ Eliminate infusions Eliminate infusions

Feedback Immediate feedback to all team members: Immediate feedback to all team members: Call to community ED Call to community ED summary <24 hours summary <24 hours Monthly case reviews Monthly case reviews Quarterly reports to community hospitals Quarterly reports to community hospitals

Conclusion Conventional transfer system fail in STEMI patients Conventional transfer system fail in STEMI patients Helicopter transfer services are central to regional system development Helicopter transfer services are central to regional system development Assemble your team, build your ‘tool box’ Assemble your team, build your ‘tool box’

Conclusion Primary angioplasty: improves survival Primary angioplasty: improves survival - Particular benefit in shock/CHF/”big one” - Particular benefit in shock/CHF/”big one” Cardiac regionalization critical Cardiac regionalization critical - Maximizing cantidacy primary angioplasty - Maximizing cantidacy primary angioplasty - Rescue angioplasty (20-40% lytic failure) - Rescue angioplasty (20-40% lytic failure)

Cutting Edge Rural EMS integration: ‘Scene STEMI’ Rural EMS integration: ‘Scene STEMI’ ECG telemetry systems ECG telemetry systems Rural volunteer basic EMT Rural volunteer basic EMT Better PCI vs Lytic decision tool Better PCI vs Lytic decision tool Ground contingency models Ground contingency models